An epidemiological surveillance study of glycemic response of breakable fixed dose combination (FDC) of gliclazide 60mg + metformin 500mg in 759 Indian patients with T2DM showed that 33.2% of patients achieved glycemic control with one tablet, 50% with one and half tablets and 77.5% with ...
An epidemiological surveillance study of glycemic response of breakable fixed dose combination (FDC) of gliclazide 60mg + metformin 500mg in 759 Indian patients with T2DM showed that 33.2% of patients achieved glycemic control with one tablet, 50% with one and half tablets and 77.5% with ...
SGNCF1 showed spherical shape, small particle size (106.3 ± 2.69 nm), good zeta potential (−18.2 ± 1.30 mV), small PDI (0.222 ± 0.104) and high entrapment efficiency (86.27 ± 0.222%). The solubility, dissolution rate and bioavailability of gliclazide ...